Disposition and metabolism of LY2603618, a Chk-1 inhibitor following intravenous administration in patients with advanced and/or metastatic solid tumors
Wickremsinhe, Enaksha R., Hynes, Scott M., Palmieri, Margo D., Mitchell, Malcolm I., Abraham, Trent L., Rehmel, Jessica Fayer, Chana, Emilie, Jost, Lorenz M., Cassidy, Kenneth C.
Published in Xenobiotica (01.09.2014)
Published in Xenobiotica (01.09.2014)
Get full text
Journal Article